FGF21 and Hepatic steatosis: Genetic impairment of adipocytes OxPhos function in vivo also protects mice from DIO and insulin resistance, with ablation of FGF21 in this model leading to increased body weight and adiposity, and hepatic steatosis after 8 weeks on high-fat diet (HFD) (41).